FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310930458> ?p ?o ?g. }

• W4310930458 abstract "Abstract Object This study evaluates the association between antivirals (Molnupiravir and Nirmatrelvir-Ritonavir) and all-cause and respiratory mortality and organ dysfunction among high-risk COVID-19 patients during an Omicron outbreak. Methods Two cohorts, Nirmatrelvir-Ritonavir vs. control and Molnupiravir vs. control, were constructed with inverse probability treatment weighting to balance baseline characteristics. Cox proportional hazards models evaluated the association of their use with all-cause mortality, respiratory mortality, and all-cause sepsis (a composite of circulatory shock, respiratory failure, acute liver injury, coagulopathy, and acute liver impairment). Patients recruited were hospitalized and diagnosed with the COVID-19 Omicron variant between February 22, 2022 to April 15, 2022, and followed up until May 15, 2022. Results The study included 17,704 patients. There were 4.67 and 22.7 total mortalities per 1000 person-days in the Nirmatrelvir-Ritonavir and control groups respectively before adjustment (weighted incidence rate ratio, -18.1 [95%CI, -23.0 to -13.2]; hazard ratio, 0.18 [95%CI, 0.11–0.29]). There were 6.64 and 25.9 total mortalities per 1000 person-days in the Molnupiravir and control groups respectively before adjustment (weighted incidence rate ratio per 1000 person-days, -19.3 [95%CI, -22.6 to -15.9]; hazard ratio, 0.23 [95%CI, 0.18–0.30]). In all-cause sepsis, there were 13.7 and 35.4 organ dysfunction events per 1000 person-days in the Nirmatrelvir-Ritonavir and control groups respectively before adjustment (weighted incidence rate ratio per 1000 person-days, -21.7 [95%CI, -26.3 to -17.1]; hazard ratio, 0.44 [95%CI, 0.38–0.52]). There were 23.7 and 40.8 organ dysfunction events in the Molnupiravir and control groups respectively before adjustment (weighted incidence ratio per 1000 person-days, -17.1 [95%CI, -20.6 to -13.6]; hazard ratio, 0.63 [95%CI, 0.58–0.69]). Conclusions Among COVID-19 hospitalized patients, use of either Nirmatrelvir-Ritonavir or Molnupiravir compared with no antiviral use was associated with a significantly lower incidence of 28-day all-cause and respiratory mortality and sepsis." @default.
• W4310930458 created "2022-12-21" @default.
• W4310930458 creator A5009354677 @default.
• W4310930458 creator A5011952009 @default.
• W4310930458 creator A5022168128 @default.
• W4310930458 creator A5026824851 @default.
• W4310930458 creator A5028868956 @default.
• W4310930458 creator A5031806499 @default.
• W4310930458 creator A5033578969 @default.
• W4310930458 creator A5041366054 @default.
• W4310930458 creator A5046014289 @default.
• W4310930458 creator A5057304049 @default.
• W4310930458 creator A5064703190 @default.
• W4310930458 creator A5068393170 @default.
• W4310930458 creator A5076310650 @default.
• W4310930458 creator A5077278585 @default.
• W4310930458 creator A5078415456 @default.
• W4310930458 creator A5091460022 @default.
• W4310930458 date "2022-12-09" @default.
• W4310930458 modified "2023-10-15" @default.
• W4310930458 title "Association of Molnupiravir and Nirmatrelvir-Ritonavir with Reduced Mortality and All-cause Sepsis in Hospitalized Patients Infected with Omicron Variant of SARS-CoV-2: A Territory-Wide Prospective Cohort Study" @default.
• W4310930458 cites W2044236798 @default.
• W4310930458 cites W2138219153 @default.
• W4310930458 cites W2280404143 @default.
• W4310930458 cites W2334365745 @default.
• W4310930458 cites W2755626276 @default.
• W4310930458 cites W2794452209 @default.
• W4310930458 cites W2894422883 @default.
• W4310930458 cites W3009885589 @default.
• W4310930458 cites W3032386763 @default.
• W4310930458 cites W3044069820 @default.
• W4310930458 cites W3199202358 @default.
• W4310930458 cites W4200051875 @default.
• W4310930458 cites W4200119705 @default.
• W4310930458 cites W4210365826 @default.
• W4310930458 cites W4214700364 @default.
• W4310930458 cites W4224950216 @default.
• W4310930458 cites W4226236384 @default.
• W4310930458 cites W4281389498 @default.
• W4310930458 doi "https://doi.org/10.21203/rs.3.rs-2045443/v1" @default.
• W4310930458 hasPublicationYear "2022" @default.
• W4310930458 type Work @default.
• W4310930458 citedByCount "0" @default.
• W4310930458 crossrefType "posted-content" @default.
• W4310930458 hasAuthorship W4310930458A5009354677 @default.
• W4310930458 hasAuthorship W4310930458A5011952009 @default.
• W4310930458 hasAuthorship W4310930458A5022168128 @default.
• W4310930458 hasAuthorship W4310930458A5026824851 @default.
• W4310930458 hasAuthorship W4310930458A5028868956 @default.
• W4310930458 hasAuthorship W4310930458A5031806499 @default.
• W4310930458 hasAuthorship W4310930458A5033578969 @default.
• W4310930458 hasAuthorship W4310930458A5041366054 @default.
• W4310930458 hasAuthorship W4310930458A5046014289 @default.
• W4310930458 hasAuthorship W4310930458A5057304049 @default.
• W4310930458 hasAuthorship W4310930458A5064703190 @default.
• W4310930458 hasAuthorship W4310930458A5068393170 @default.
• W4310930458 hasAuthorship W4310930458A5076310650 @default.
• W4310930458 hasAuthorship W4310930458A5077278585 @default.
• W4310930458 hasAuthorship W4310930458A5078415456 @default.
• W4310930458 hasAuthorship W4310930458A5091460022 @default.
• W4310930458 hasBestOaLocation W43109304581 @default.
• W4310930458 hasConcept C120665830 @default.
• W4310930458 hasConcept C121332964 @default.
• W4310930458 hasConcept C126322002 @default.
• W4310930458 hasConcept C188816634 @default.
• W4310930458 hasConcept C207103383 @default.
• W4310930458 hasConcept C2778384902 @default.
• W4310930458 hasConcept C2778426790 @default.
• W4310930458 hasConcept C44249647 @default.
• W4310930458 hasConcept C50382708 @default.
• W4310930458 hasConcept C61511704 @default.
• W4310930458 hasConcept C71924100 @default.
• W4310930458 hasConcept C72563966 @default.
• W4310930458 hasConcept C90924648 @default.
• W4310930458 hasConceptScore W4310930458C120665830 @default.
• W4310930458 hasConceptScore W4310930458C121332964 @default.
• W4310930458 hasConceptScore W4310930458C126322002 @default.
• W4310930458 hasConceptScore W4310930458C188816634 @default.
• W4310930458 hasConceptScore W4310930458C207103383 @default.
• W4310930458 hasConceptScore W4310930458C2778384902 @default.
• W4310930458 hasConceptScore W4310930458C2778426790 @default.
• W4310930458 hasConceptScore W4310930458C44249647 @default.
• W4310930458 hasConceptScore W4310930458C50382708 @default.
• W4310930458 hasConceptScore W4310930458C61511704 @default.
• W4310930458 hasConceptScore W4310930458C71924100 @default.
• W4310930458 hasConceptScore W4310930458C72563966 @default.
• W4310930458 hasConceptScore W4310930458C90924648 @default.
• W4310930458 hasLocation W43109304581 @default.
• W4310930458 hasOpenAccess W4310930458 @default.
• W4310930458 hasPrimaryLocation W43109304581 @default.
• W4310930458 hasRelatedWork W1975198268 @default.
• W4310930458 hasRelatedWork W2113390168 @default.
• W4310930458 hasRelatedWork W2119576612 @default.
• W4310930458 hasRelatedWork W2970151791 @default.
• W4310930458 hasRelatedWork W2980864243 @default.
• W4310930458 hasRelatedWork W2987985474 @default.
• W4310930458 hasRelatedWork W3113787349 @default.
• W4310930458 hasRelatedWork W3129483513 @default.
• W4310930458 hasRelatedWork W3174612885 @default.
• W4310930458 hasRelatedWork W4224304419 @default.

• next